| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Guidelines |
| Article Title |
Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sameer Al Awadhi, Abdulla Al Hassani, Sara El Ouali, Mohammad Badre Alam, Cecilio Azar, Filippos Georgopoulos, Ahmad N Jazzar, Ahmed M Khassouan, Zaher Koutoubi, Rahul A Nathwani and Mohammed Nabil Quraishi |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Emirates Gastroenterology and Hepatology Society |
001802 |
|
| Corresponding Author |
Mohammed Nabil Quraishi, FRCP, PhD, Department of Gastroenterology and Hepatology, Sheikh Shakhbout Medical City, Pure Health, Al Mafraq, Abu Dhabi 00000, United Arab Emirates. nabilquraishi@gmail.com |
| Key Words |
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Consensus guidance; United Arab Emirates |
| Core Tip |
This second edition of the United Arab Emirates inflammatory bowel disease consensus guidance offers updated national recommendations due to significant therapeutic advances since the first edition. Developed via Delphi methodology, its 188 statements cover diagnosis, newer pharmacotherapies interleukin-23, Janus kinase 1, and sphingosine-1-phosphate inhibitors), treat-to-target strategies, and special considerations including inflammatory bowel disease in pregnancy and complex disease. It emphasizes early effective treatment and addresses local challenges, aiming to standardize United Arab Emirates practice, inform policy, and align with international standards to improve patient outcomes. |
| Publish Date |
2025-09-18 09:55 |
| Citation |
<p>Al Awadhi S, Al Hassani A, El Ouali S, Alam MB, Azar C, Georgopoulos F, Jazzar AN, Khassouan AM, Koutoubi Z, Nathwani RA, Quraishi MN. Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease. <i>World J Gastroenterol</i> 2025; 31(35): 109882</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i35/109882.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i35.109882 |
